Gut microbiota manipulation as an epilepsy treatment.

Area of Science:

• Neuroscience
• Microbiology
• Gastroenterology

Background:

• The gut microbiota (GM) significantly impacts central nervous system (CNS) functions through the microbiota-gut-brain (MGB) axis.
• Alterations in GM composition are linked to various neurological and neuropsychiatric disorders, including epilepsy.
• Emerging research suggests GM plays a role in regulating neuronal excitability and seizure activity.

Purpose of the Study:

• To review the therapeutic potential of gut microbiota manipulation in epilepsy.
• To explore novel treatment strategies like probiotics, prebiotics, and symbiotics for epilepsy.
• To identify methodological challenges in designing translational clinical trials for gut microbiota-based epilepsy therapies.

Main Methods:

• Literature review of studies investigating the MGB axis and epilepsy.
• Analysis of research on the impact of GM on neuronal hyperexcitability and epileptogenesis.
• Examination of current and proposed therapeutic interventions targeting the GM for epilepsy.

Main Results:

• Evidence suggests a correlation between GM dysbiosis and epilepsy.
• Gut microbiota modulation shows promise as an adjunctive therapy for epilepsy.
• Probiotics, prebiotics, and symbiotics are being explored for their anti-seizure effects.

Conclusions:

• The gut microbiota represents a potential therapeutic target for epilepsy management.
• Further research and well-designed clinical trials are needed to validate microbiota-based interventions.
• Addressing methodological challenges is crucial for advancing translational research in this field.